Skip to main content

Table 2 Comparsion of outcome variables characterizing the measurement of the SP, SPAP variable at baseline and after application of KT

From: Does kinesiotaping can improve static stability of the knee after anterior cruciate ligament rupture? A randomized single-blind, placebo‐controlled trial

  Baseline Post X difference
(95% CI)
pa ESa
X±SD X±SD
SP [mm] Experimental 1107.3±288.8 927.8±295.9 -179.5 (1.81 to 2.01) <0.001 0.61
Placebo 1073.9±266.5 1033.1±289.2 -40.8 (1.45 to 2.56) 0.060 0.14
pb 0.638 0.043    
ESb 0.11 0.36    
SPAP [mm] Experimental 818.3±238.4 622.4±254.8 -195.9 (2.05 to 2.91) <0.001 0.79
Placebo 702.4±219.3 698.1±217.5 -4.3 (1.01 to 3.01) 0.067 0.02
pb 0.464 0.039    
ESb 0.50 0.32    
SPML [mm] Experimental 763.9±238.6 681.2±234.0 -82.7(2.21 to 3.34) 0.031 0.35
Placebo 752.1±208.6 728.6±194.8 -63.5 (1.26 to 2.69) 0.221 0.11
pb 0.882 0.046    
ESb 0.05 0.22    
MV
[mm/s]
Experimental 36.7±8.7 32.2±9.3 -4.5 (1.98 to 2.78) 0.039 0.49
Placebo 37.3±±9.9 35.6±9.5 -1.7 (1.45 to 2.21) 0.089 0.17
pb 0.079 0.042    
ESb 0.06 0.36    
MVAP
[mm/s]
Experimental 23.2±5.8 19.2±7.6 -4 (1.67 to 2.56) 0.043 0.59
Placebo 23.8±7.4 22.2±7.9 -1.6 (1.75 to 3.01) 0.079 0.20
pb 0.096 0.039    
ESb 0.09 0.38    
MVML
[mm/s]
Experimental 24.4±6.8 20.3±6.5 -4.1 (1.21 to 2.45) 0.031 0.61
Placebo 25.1±6.4 23.1±6.2 -2 (0.92 to 3.42) 0.112 0.31
pb 0.065 0.024    
ESb 0.10 0.44    
  1. Baseline the measurement before application of KT; Post the measurement after application of KT; SPthe total path length; SPAP the path length on the Y axis; SPML the path length on the X axis; MV mean velocity of the COP in XY axes; MVAP mean velocity of the CoP in the Y axis; MVML mean velocity of the CoP in the X axis; pap-value; between baseline and post-KT within each group; pbp-value between study groups; ESa effect size (Cohen d) within each group; ESb effect size (Cohen d) between study groups; p < 0,05; CI confidence interval